CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 138 filers reported holding CHINA BIOLOGIC PRODS INC in Q2 2016. The put-call ratio across all filers is 1.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $1,579,000 | +8.7% | 13,961 | -3.8% | 0.02% | +6.7% |
Q1 2017 | $1,453,000 | -24.6% | 14,510 | -19.1% | 0.02% | -28.6% |
Q4 2016 | $1,928,000 | -10.5% | 17,929 | +3.6% | 0.02% | -30.0% |
Q3 2016 | $2,155,000 | +2.4% | 17,312 | -12.5% | 0.03% | +11.1% |
Q2 2016 | $2,104,000 | -6.6% | 19,793 | +0.6% | 0.03% | -12.9% |
Q1 2016 | $2,253,000 | -25.9% | 19,684 | -7.7% | 0.03% | -16.2% |
Q4 2015 | $3,040,000 | – | 21,336 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
Kylin Management | 188,226 | $21,676,000 | 2.36% |
Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |